OncoAlly™ BRCA1/2 Analysis

Test Code – OA014

OncoAlly™ BRCA1/2 Analysis Analysis uses a whole genome sequencing platform to analyze the BRCA1 and BRCA2 genes for genetic variants associated with hereditary breast, ovarian, pancreatic and prostate cancer.

When to Order

Order this test when a patient has a personal or family history suggestive of hereditary breast or ovarian cancer predisposition or when germline variant analysis for hereditary breast or ovarian cancer predisposition is necessary to guide medical management.

Included Analyses

  • Sequence analysis of hereditary cancer-associated genes (single nucleotide variants, deletions, insertions, and characterized intronic variants)
  • Copy number variant analysis of hereditary cancer-associated genes (duplications/deletions, mobile element insertions, and inversions)

Optionally Includes:

Included Genes

View a list of cancers associated with each gene.

Test Performance

Sensitivity for SNVs
 >  %
Specificity for SNVs
Positive predictive value for SNVs
Clinical sensitivity for structural variants

CPT Codes


The CPT codes provided are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Accepted Specimens



Specimen Requirements



Specimen Requirements



Specimen Requirements

Turnaround Time

A report will be issued within 4-8 weeks from receipt of all sample requirements.